Aspirin resistance in patients with acute coronary syndrome. Part 2

@article{Frolova2011AspirinRI,
  title={Aspirin resistance in patients with acute coronary syndrome. Part 2},
  author={N. S. Frolova and R. M. Shakhnovich and E. M. Kaznacheeva and O. V. Sirotkina and A. Dobrovolskyi},
  journal={Cardiovascular Therapy and Prevention},
  year={2011},
  volume={10},
  pages={47-52}
}
  • N. S. Frolova, R. M. Shakhnovich, +2 authors A. Dobrovolskyi
  • Published 2011
  • Medicine
  • Cardiovascular Therapy and Prevention
    • Цель. Определить частоту развития резистентности к аспирину у больных с острым коронарным синдромом (ОКС), клинические особенности, возможности преодоления и влияние на прогноз. Материал и методы. Включены 100 больных с ОКС, лечившихся аспирином. В качестве критерия резистентности использован уровень агрегации тромбоцитов (АТ) с арахидоновой кислотой ≥ 20 % на 7 сут. терапии аспирином. Дополнительно был исследован метаболит тромбоксана А2 (ТхА2) – 11 дегидро тромбоксан В2 (11ДГТхВ2… CONTINUE READING
    View PDF

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

      References

      SHOWING 1-10 OF 20 REFERENCES
      Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
      • 103
      Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
      • 978
      • PDF
      Glycoprotein IIIA Gene (PIA) Polymorphism and Aspirin Resistance: Is There Any Correlation?
      • 59
      The CYP 3 A 4 * 3 Allele : Is It Really Rare ?
      • 15
      • PDF
      The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
      • 507
      • PDF
      Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
      • 462
      • PDF
      Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.
      • 169
      Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.
      • 22
      Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
      • 335
      • PDF
      Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.
      • 225